Literature DB >> 1826231

Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas.

T Wagata1, K Ishizaki, M Imamura, Y Shimada, M Ikenaga, T Tobe.   

Abstract

We have analyzed allelic deletion at 23 loci on 18 different chromosomes in 35 esophageal squamous cell carcinoma tissues by using restriction fragment length polymorphism markers. Loss of heterozygosity was detected on chromosomes 2, 3, 6, 7, 11-14, 16-18, 21, and 22, while no loss was detected on chromosomes 1, 4, and 8-10. Only the loss of chromosome 17p was detected with high frequency (45%), and losses on other chromosomes had frequencies of less than 22%. These losses with low frequencies might be random losses caused by chromosomal rearrangement during the course of tumor development and progression. On the contrary, the loss of 17p might play an important role in the development of esophageal squamous cell carcinoma, such as inactivation of a tumor suppressor gene. Amplification of the int-2 gene was observed in 39% of the tumors. However, no significant relationship between int-2 amplification and the deletion of any chromosome was detected.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826231

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  DNA repair gene status in oesophageal cancer.

Authors:  R Naidoo; R Chetty
Journal:  Mol Pathol       Date:  1999-06

2.  Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagectomy.

Authors:  Y Shimada; M Imamura; I Shibagaki; H Tanaka; T Miyahara; M Kato; K Ishizaki
Journal:  Ann Surg       Date:  1997-08       Impact factor: 12.969

3.  Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction.

Authors:  S J Meltzer; J Yin; Y Huang; T K McDaniel; C Newkirk; O Iseri; B Vogelstein; J H Resau
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

4.  Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).

Authors:  S Inada; T Koto; K Futami; S Arima; A Iwashita
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

5.  Aberrations in the mismatch repair genes and the clinical impact on oesophageal squamous carcinomas from a high incidence area in South Africa.

Authors:  R Naidoo; A Ramburan; A Reddi; R Chetty
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

Review 6.  The links between axin and carcinogenesis.

Authors:  S Salahshor; J R Woodgett
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

7.  Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.

Authors:  R F Boynton; P L Blount; J Yin; V L Brown; Y Huang; Y Tong; T McDaniel; C Newkirk; J H Resau; W H Raskind; R C Haggitt; B J Reid; S J Meltzer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

Review 8.  Multimodality treatment of cancer arising from Barrett's epithelium.

Authors:  J A Roth
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.

Authors:  W Jiang; Y J Zhang; S M Kahn; M C Hollstein; R M Santella; S H Lu; C C Harris; R Montesano; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

10.  Molecular and cellular features of esophageal cancer cells.

Authors:  T Nishihira; Y Hashimoto; M Katayama; S Mori; T Kuroki
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.